BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ross JS, Cronin M. Whole cancer genome sequencing by next-generation methods. Am J Clin Pathol 2011;136:527-39. [PMID: 21917674 DOI: 10.1309/AJCPR1SVT1VHUGXW] [Cited by in Crossref: 129] [Cited by in F6Publishing: 111] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Samlali K, Thornbury M, Venter A. Community-led risk analysis of direct-to-consumer whole-genome sequencing. Biochem Cell Biol 2022;100:499-509. [PMID: 35939839 DOI: 10.1139/bcb-2021-0506] [Reference Citation Analysis]
2 Hanbazazh M, Morlote D, Mackinnon AC, Harada S. Utility of Single-Gene Testing in Cancer Specimens. Clinics in Laboratory Medicine 2022. [DOI: 10.1016/j.cll.2022.05.001] [Reference Citation Analysis]
3 Hussen BM, Abdullah ST, Salihi A, Sabir DK, Sidiq KR, Rasul MF, Hidayat HJ, Ghafouri-Fard S, Taheri M, Jamali E. The emerging roles of NGS in clinical oncology and personalized medicine. Pathol Res Pract 2022;230:153760. [PMID: 35033746 DOI: 10.1016/j.prp.2022.153760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Baranova OY, Shirin A. A Current View on Pathogenesis, Diagnosis, and Treatment of Some Rare Acute Leukemia Variants. Клиническая онкогематология 2022;15:307-326. [DOI: 10.21320/2500-2139-2022-15-4-307-326] [Reference Citation Analysis]
5 Zhu L, Xie S, Yang C, Hua N, Wu Y, Wang L, Ni W, Tong X, Fei M, Wang S. Current Progress in Investigating Mature T- and NK-Cell Lymphoma Gene Aberrations by Next-Generation Sequencing (NGS). Cancer Manag Res 2021;13:5275-86. [PMID: 34239326 DOI: 10.2147/CMAR.S299505] [Reference Citation Analysis]
6 Wang J, Yu P, Luo J, Sun Z, Yu J, Wang J. Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC). Front Pharmacol 2021;12:626972. [PMID: 33935718 DOI: 10.3389/fphar.2021.626972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Chen P, Yu X, Huang H, Zeng W, He X, Liu M, Huang B. Evaluation of Ion Torrent next-generation sequencing for thalassemia diagnosis. J Int Med Res 2020;48:300060520967778. [PMID: 33342339 DOI: 10.1177/0300060520967778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Majewska A, Budny B, Ziemnicka K, Ruchała M, Wierzbicka M. Head and Neck Paragangliomas-A Genetic Overview. Int J Mol Sci 2020;21:E7669. [PMID: 33081307 DOI: 10.3390/ijms21207669] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Asthana V, Stern BS, Tang Y, Bugga P, Li A, Ferguson A, Asthana A, Bao G, Drezek RA. Development of a Novel Class of Self-Assembling dsRNA Cancer Therapeutics: A Proof-of-Concept Investigation. Mol Ther Oncolytics 2020;18:419-31. [PMID: 32913891 DOI: 10.1016/j.omto.2020.07.013] [Reference Citation Analysis]
10 Yao H, Wu C, Chen Y, Guo L, Chen W, Pan Y, Fu X, Wang G, Ding Y. Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients. Mol Genet Genomic Med 2020;8:e1369. [PMID: 32638549 DOI: 10.1002/mgg3.1369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Asthana V, Stern BS, Tang Y, Bugga P, Li A, Ferguson A, Asthana A, Bao G, Drezek RA. Development of a Novel Class of Self-Assembling dsRNA Cancer Therapeutics: a Proof of Concept Investigation.. [DOI: 10.1101/2020.04.22.055905] [Reference Citation Analysis]
12 Gargallo P, Font de Mora J, Berlanga P, Calabria I, Llavador M, Pedrola L, Panadero J, Dolz S, Zúñiga Á, Oltra JS, Escobar P, Yáñez Y, Aparisi MJ, Martinez-matilla M, Segura V, Esquembre C, Del Cañizo M, Moreno MJ, Márquez C, Cañete A, Castel V. Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative. transl med commun 2019;4:10. [DOI: 10.1186/s41231-019-0042-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yu J, Hu Y, Xu Y, Wang J, Kuang J, Zhang W, Shao J, Guo D, Wang Y. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features. BMC Cancer 2019;19:263. [PMID: 30902072 DOI: 10.1186/s12885-019-5433-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhang L, Luo M, Yang H, Zhu S, Cheng X, Qing C. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients. J Ovarian Res 2019;12:19. [PMID: 30786925 DOI: 10.1186/s13048-019-0494-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
15 Sapna G, Gokul S. Next generation sequencing in oral disease diagnostics. World J Stomatol 2018; 6(2): 6-10 [DOI: 10.5321/wjs.v6.i2.6] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Proctor A, Zigoneanu IG, Wang Q, Sims CE, Lawrence DS, Allbritton NL. Development of a protease-resistant reporter to quantify BCR-ABL activity in intact cells. Analyst 2016;141:6008-17. [PMID: 27704073 DOI: 10.1039/c6an01378c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
17 Liang C, Wu Z, Gan X, Liu Y, You Y, Liu C, Zhou C, Liang Y, Mo H, Chen AM, Zhang J. Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing. Yonsei Med J 2018;59:13-9. [PMID: 29214771 DOI: 10.3349/ymj.2018.59.1.13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
18 Luo Z, Fan X, Su Y, Huang YS. Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants. Bioinformatics 2018;34:2004-11. [PMID: 29385401 DOI: 10.1093/bioinformatics/bty043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
19 Kerr KM, Laing GM. Precision Medicine in Lung Cancer. Precision Molecular Pathology of Lung Cancer 2018. [DOI: 10.1007/978-3-319-62941-4_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Jenster GW. De moleculaire biologie van urologische tumoren. Leerboek urologie 2018. [DOI: 10.1007/978-90-368-2064-6_14] [Reference Citation Analysis]
21 Chudnovsky Y, Kumar RD, Schrock AB, Connelly C, Gowen K, Frampton GM, Erlich RL, Stephens PJ, Miller VA, Ross JS, Ali SM, Bose R. Response of a Metastatic Breast Carcinoma With a Previously Uncharacterized ERBB2 G776V Mutation to Human Epidermal Growth Factor Receptor 2–Targeted Therapy. JCO Precision Oncology 2017. [DOI: 10.1200/po.16.00037] [Reference Citation Analysis]
22 de Abreu FB, Peterson JD, Amos CI, Wells WA, Tsongalis GJ. Effective quality management practices in routine clinical next-generation sequencing. Clin Chem Lab Med 2016;54:761-71. [PMID: 26872315 DOI: 10.1515/cclm-2015-1190] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
23 Reed PJ, Wang M, Erwin JA, Paquola ACM, Gage FH. Single-Cell Whole Genome Amplification and Sequencing to Study Neuronal Mosaicism and Diversity. Neuromethods 2017. [DOI: 10.1007/978-1-4939-7280-7_13] [Reference Citation Analysis]
24 Song Y, Tian T, Shi Y, Liu W, Zou Y, Khajvand T, Wang S, Zhu Z, Yang C. Enrichment and single-cell analysis of circulating tumor cells. Chem Sci 2017;8:1736-51. [PMID: 28451298 DOI: 10.1039/c6sc04671a] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 16.4] [Reference Citation Analysis]
25 Karpathiou G, Batistatou A, Forest F, Clemenson A, Peoc'h M. Basic Molecular Pathology and Cytogenetics for Practicing Pathologists: Correlation With Morphology and With a Focus on Aspects of Diagnostic or Therapeutic Utility. Adv Anat Pathol 2016;23:368-80. [PMID: 27740961 DOI: 10.1097/PAP.0000000000000124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
26 Calabria I, Pedrola L, Berlanga P, Aparisi MJ, Sánchez-izquierdo D, Cañete A, Cervera J, Millán JM, Castel V. The new challenge in oncology: Next-generation sequencing and its application in precision medicine. Anales de Pediatría (English Edition) 2016;85:273.e1-7. [DOI: 10.1016/j.anpede.2016.05.002] [Reference Citation Analysis]
27 Sabour L, Sabour M, Ghorbian S. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis. Pathol Oncol Res 2017;23:225-34. [PMID: 27722982 DOI: 10.1007/s12253-016-0124-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
28 Bruijns B, van Asten A, Tiggelaar R, Gardeniers H. Microfluidic Devices for Forensic DNA Analysis: A Review. Biosensors (Basel) 2016;6:E41. [PMID: 27527231 DOI: 10.3390/bios6030041] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 11.3] [Reference Citation Analysis]
29 Endrullat C, Glökler J, Franke P, Frohme M. Standardization and quality management in next-generation sequencing. Appl Transl Genom 2016;10:2-9. [PMID: 27668169 DOI: 10.1016/j.atg.2016.06.001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 127] [Article Influence: 16.6] [Reference Citation Analysis]
30 Jang JS, Wang X, Vedell PT, Wen J, Zhang J, Ellison DW, Evans JM, Johnson SH, Yang P, Sukov WR, Oliveira AM, Vasmatzis G, Sun Z, Jen J, Yi ES. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma. J Thorac Oncol 2016;11:1891-900. [PMID: 27343444 DOI: 10.1016/j.jtho.2016.06.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
31 Marino-Enriquez A. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications. Surg Pathol Clin 2015;8:525-37. [PMID: 26297069 DOI: 10.1016/j.path.2015.06.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
32 Sasaki Y, Tamura M, Koyama R, Nakagaki T, Adachi Y, Tokino T. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing. World J Gastroenterol 2016; 22(7): 2284-2293 [PMID: 26900290 DOI: 10.3748/wjg.v22.i7.2284] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
33 Neumaier M. Zirkulierende Nukleinsäuren – ein neues Universum in der laboratoriumsmedizinischen Diagnostik. LaboratoriumsMedizin 2016;40. [DOI: 10.1515/labmed-2016-0053] [Reference Citation Analysis]
34 Tam AL, Lim HJ, Wistuba II, Tamrazi A, Kuo MD, Ziv E, Wong S, Shih AJ, Webster RJ 3rd, Fischer GS, Nagrath S, Davis SE, White SB, Ahrar K. Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel. J Vasc Interv Radiol 2016;27:8-19. [PMID: 26626860 DOI: 10.1016/j.jvir.2015.10.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 8.3] [Reference Citation Analysis]
35 Biswas A, Rao VR, Seth S, Maulik SK. Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine. Mol Biol Rep 2014;41:4881-8. [PMID: 24908287 DOI: 10.1007/s11033-014-3418-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
36 Gurzadyan VG, Yan H, Vlahovic G, Kashin A, Killela P, Reitman Z, Sargsyan S, Yegorian G, Milledge G, Vlahovic B. Detecting somatic mutations in genomic sequences by means of Kolmogorov-Arnold analysis. R Soc Open Sci 2015;2:150143. [PMID: 26361546 DOI: 10.1098/rsos.150143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 Fong KM, Daniels M, Goh F, Yang IA, Bowman RV. The current and future roles of genomics. Lung Cancer. [DOI: 10.1183/2312508x.10009614] [Reference Citation Analysis]
38 De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, Izzo P, Delrio P. Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 2015;34:1087-1096. [PMID: 26151224 DOI: 10.3892/or.2015.4108] [Cited by in Crossref: 183] [Cited by in F6Publishing: 201] [Article Influence: 22.9] [Reference Citation Analysis]
39 Petric RC, Pop LA, Jurj A, Raduly L, Dumitrascu D, Dragos N, Neagoe IB. Next generation sequencing applications for breast cancer research. Clujul Med 2015;88:278-87. [PMID: 26609257 DOI: 10.15386/cjmed-486] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
40 Javle M, Churi C, Kang HC, Shroff R, Janku F, Surapaneni R, Zuo M, Barrera C, Alshamsi H, Krishnan S, Mishra L, Wolff RA, Kaseb AO, Thomas MB, Siegel AB. HER2/neu-directed therapy for biliary tract cancer. J Hematol Oncol. 2015;8:58. [PMID: 26022204 DOI: 10.1186/s13045-015-0155-z] [Cited by in Crossref: 145] [Cited by in F6Publishing: 157] [Article Influence: 18.1] [Reference Citation Analysis]
41 Hakhverdyan Z, Domanski M, Hough LE, Oroskar AA, Oroskar AR, Keegan S, Dilworth DJ, Molloy KR, Sherman V, Aitchison JD, Fenyö D, Chait BT, Jensen TH, Rout MP, LaCava J. Rapid, optimized interactomic screening. Nat Methods 2015;12:553-60. [PMID: 25938370 DOI: 10.1038/nmeth.3395] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
42 Muley TR, Herth FJ, Schnabel PA, Dienemann H, Meister M. From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience. Transl Lung Cancer Res 2012;1:111-21. [PMID: 25806167 DOI: 10.3978/j.issn.2218-6751.2011.12.07] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
43 Luchetti A, Walsh D, Rodger F, Clark G, Martin T, Irving R, Sanna M, Yao M, Robledo M, Neumann HP, Woodward ER, Latif F, Abbs S, Martin H, Maher ER. Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis. Int J Endocrinol 2015;2015:138573. [PMID: 25883647 DOI: 10.1155/2015/138573] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
44 Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, Ottaviano V, Queirolo P. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. Onco Targets Ther 2015;8:157-68. [PMID: 25653539 DOI: 10.2147/OTT.S39096] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 12.4] [Reference Citation Analysis]
45 De Braekeleer M, De Braekeleer E, Douet-guilbert N. Whole-Genome/Exome Sequencing in Acute Leukemia: From Research to Clinics. Next Generation Sequencing in Cancer Research, Volume 2 2015. [DOI: 10.1007/978-3-319-15811-2_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Curry JL, Tetzlaff MT, Lazar AJ, Prieto VG. Application of Molecular Pathology to Cutaneous Melanocytic Lesions. Molecular Pathology Library 2015. [DOI: 10.1007/978-1-4939-2861-3_6] [Reference Citation Analysis]
47 Wilson MA, Nathanson KL. Molecular Diagnostics and Tumor Mutational Analysis. Cancer Drug Discovery and Development 2015. [DOI: 10.1007/978-1-4939-2143-0_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J, Zuo M, Zinner R, Hong D, Meric-Bernstam F, Janku F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills G, Javle M. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS One. 2014;9:e115383. [PMID: 25536104 DOI: 10.1371/journal.pone.0115383] [Cited by in Crossref: 272] [Cited by in F6Publishing: 309] [Article Influence: 30.2] [Reference Citation Analysis]
49 Kenmotsu H, Serizawa M, Koh Y, Isaka M, Takahashi T, Taira T, Ono A, Maniwa T, Takahashi S, Mori K, Endo M, Abe M, Hayashi I, Nakajima T, Ohde Y, Yamamoto N. Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC Cancer 2014;14:786. [PMID: 25348872 DOI: 10.1186/1471-2407-14-786] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
50 Singh RR, Patel KP, Routbort MJ, Aldape K, Lu X, Manekia J, Abraham R, Reddy NG, Barkoh BA, Veliyathu J. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Br J Cancer. 2014;111:2014-2023. [PMID: 25314059 DOI: 10.1038/bjc.2014.518] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 7.6] [Reference Citation Analysis]
51 Hansen AR, Bedard PL. Clinical application of high-throughput genomic technologies for treatment selection in breast cancer. Breast Cancer Res 2013;15:R97. [PMID: 24135425 DOI: 10.1186/bcr3558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
52 Pirooznia M, Kramer M, Parla J, Goes FS, Potash JB, McCombie WR, Zandi PP. Validation and assessment of variant calling pipelines for next-generation sequencing. Hum Genomics 2014;8:14. [PMID: 25078893 DOI: 10.1186/1479-7364-8-14] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
53 Ong M, Carreira S, Goodall J, Mateo J, Figueiredo I, Rodrigues DN, Perkins G, Seed G, Yap TA, Attard G, de Bono JS. Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail. Br J Cancer 2014;111:828-36. [PMID: 24983367 DOI: 10.1038/bjc.2014.350] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
54 Daniels MG, Bowman RV, Yang IA, Govindan R, Fong KM. An emerging place for lung cancer genomics in 2013. J Thorac Dis. 2013;5 Suppl 5:S491-S497. [PMID: 24163742 DOI: 10.3978/j.issn.2072-1439.2013.10.06] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
55 Wistuba II. Methodological and Practical Challenges for Personalized Therapies in Non-Small-Cell Lung Cancer. Cancer Consult: Expertise for Clinical Practice 2014. [DOI: 10.1002/9781118589199.ch74] [Reference Citation Analysis]
56 Koay PP, Sharp RR. Managing Expectational Language: Translational genetic professionals consider the clinical potential of next-generation sequencing technologies. New Genet Soc 2014;33:126-48. [PMID: 24883042 DOI: 10.1080/14636778.2014.910448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
57 Lowes LE, Allan AL. Recent advances in the molecular characterization of circulating tumor cells. Cancers (Basel). 2014;6:595-624. [PMID: 24633084 DOI: 10.3390/cancers6010595] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
58 Krishnamurti U, Silverman JF. HER2 in breast cancer: a review and update. Adv Anat Pathol 2014;21:100-7. [PMID: 24508693 DOI: 10.1097/PAP.0000000000000015] [Cited by in Crossref: 147] [Cited by in F6Publishing: 160] [Article Influence: 16.3] [Reference Citation Analysis]
59 Warnke JD, Ali HH. An efficient and scalable graph modeling approach for capturing information at different levels in next generation sequencing reads. BMC Bioinformatics 2013;14 Suppl 11:S7. [PMID: 24564333 DOI: 10.1186/1471-2105-14-S11-S7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Kim H, Chung J. ALK testing for the right patients: integration into practice and impact on clinics. Lung Cancer Management 2014;3:53-65. [DOI: 10.2217/lmt.13.71] [Reference Citation Analysis]
61 Guo R. Biology of Melanoma. The Melanocytic Proliferations 2014. [DOI: 10.1002/9781118488935.ch13] [Reference Citation Analysis]
62 Ihle MA, Fassunke J, König K, Grünewald I, Schlaak M, Kreuzberg N, Tietze L, Schildhaus HU, Büttner R, Merkelbach-Bruse S. Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations. BMC Cancer 2014;14:13. [PMID: 24410877 DOI: 10.1186/1471-2407-14-13] [Cited by in Crossref: 187] [Cited by in F6Publishing: 195] [Article Influence: 20.8] [Reference Citation Analysis]
63 Cronin M. Preanalytic Considerations for Molecular Genomic Analyses of Tissue. Methods in Pharmacology and Toxicology 2014. [DOI: 10.1007/7653_2014_17] [Reference Citation Analysis]
64 Silverman JF. Assessment of HER2 Status in Breast Cancer. Pathology Case Reviews 2014;19:261-264. [DOI: 10.1097/pcr.0000000000000055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Olzscha H, New M, La Thangue NB. Personalised Cancer Medicine: Fulfilling the Promise. eLS 2013. [DOI: 10.1002/9780470015902.a0025180] [Reference Citation Analysis]
66 Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. 2014;45:701-708. [PMID: 24508317 DOI: 10.1016/j.humpath.2013.11.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 61] [Article Influence: 5.1] [Reference Citation Analysis]
67 Nikiforova MN, Wald AI, Roy S, Durso MB, Nikiforov YE. Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab 2013;98:E1852-60. [PMID: 23979959 DOI: 10.1210/jc.2013-2292] [Cited by in Crossref: 346] [Cited by in F6Publishing: 361] [Article Influence: 34.6] [Reference Citation Analysis]
68 Braggio E, Egan JB, Fonseca R, Stewart AK. Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J. 2013;3:e127. [PMID: 23872706 DOI: 10.1038/bcj.2013.26] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
69 Tan M, Myers JN, Agrawal N. Oral cavity and oropharyngeal squamous cell carcinoma genomics. Otolaryngol Clin North Am 2013;46:545-66. [PMID: 23910469 DOI: 10.1016/j.otc.2013.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
70 Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT, Scarpa A. DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One 2013;8:e62692. [PMID: 23762227 DOI: 10.1371/journal.pone.0062692] [Cited by in Crossref: 174] [Cited by in F6Publishing: 182] [Article Influence: 17.4] [Reference Citation Analysis]
71 Hopman S, Merks J, Eussen H, Douben H, Snijder S, Hennekam R, de Klein A, Caron H. Structural genome variations in individuals with childhood cancer and tumour predisposition syndromes. European Journal of Cancer 2013;49:2170-8. [DOI: 10.1016/j.ejca.2013.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
72 Casey G, Conti D, Haile R, Duggan D. Next generation sequencing and a new era of medicine. Gut 2013;62:920-32. [PMID: 22550129 DOI: 10.1136/gutjnl-2011-301935] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
73 Crona J, Verdugo AD, Granberg D, Welin S, Stålberg P, Hellman P, Björklund P. Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma. Endocr Connect 2013;2:104-11. [PMID: 23781326 DOI: 10.1530/EC-13-0009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
74 Gullapalli RR, Lyons-Weiler M, Petrosko P, Dhir R, Becich MJ, LaFramboise WA. Clinical integration of next-generation sequencing technology. Clin Lab Med 2012;32:585-99. [PMID: 23078661 DOI: 10.1016/j.cll.2012.07.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
75 Slack GW, Gascoyne RD. Next-generation sequencing discoveries in lymphoma. Adv Anat Pathol 2013;20:110-6. [PMID: 23399796 DOI: 10.1097/PAP.0b013e3182862724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
76 Ku C, Cooper DN. Next-generation sequencing in cancer research & diagnostics. Next-Generation Sequencing & Molecular Diagnostics 2013. [DOI: 10.2217/ebo.12.46] [Reference Citation Analysis]
77 Solis LM, Wistuba II. Molecular Pathology of Lung Cancer. Diagnostic Pathology of Pleuropulmonary Neoplasia 2013. [DOI: 10.1007/978-1-4419-0787-5_14] [Reference Citation Analysis]
78 Ross JS. Circulating Tumor Cells: Liquid Biopsy for Molecular Pathology. Molecular Genetic Pathology 2013. [DOI: 10.1007/978-1-4614-4800-6_42] [Reference Citation Analysis]
79 Jenster G. De moleculaire biologie van urologische tumoren. Leerboek urologie 2013. [DOI: 10.1007/978-90-313-9809-6_14] [Reference Citation Analysis]
80 Ross JS. Diagnostic-Therapeutic Combinations. Genomic and Personalized Medicine 2013. [DOI: 10.1016/b978-0-12-382227-7.00069-0] [Reference Citation Analysis]
81 Guan YF, Li GR, Wang RJ, Yi YT, Yang L, Jiang D, Zhang XP, Peng Y. Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer. Chin J Cancer 2012;31:463-70. [PMID: 22980418 DOI: 10.5732/cjc.012.10216] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
82 Meric-Bernstam F, Mills GB. Overcoming implementation challenges of personalized cancer therapy. Nat Rev Clin Oncol 2012;9:542-8. [PMID: 22850751 DOI: 10.1038/nrclinonc.2012.127] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 9.2] [Reference Citation Analysis]
83 Daniels M, Goh F, Wright CM, Sriram KB, Relan V, Clarke BE, Duhig EE, Bowman RV, Yang IA, Fong KM. Whole genome sequencing for lung cancer. J Thorac Dis. 2012;4:155-163. [PMID: 22833821 DOI: 10.3978/j.issn.2072-1439.2012.02.01] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
84 Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, Grody WW, Hambuch T, Kalman L, Kant JA, Klein RD, Leonard DG, Lubin IM, Mao R, Nagan N, Pratt VM, Sobel ME, Voelkerding KV, Gibson JS. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn 2012;14:525-40. [PMID: 22918138 DOI: 10.1016/j.jmoldx.2012.04.006] [Cited by in Crossref: 120] [Cited by in F6Publishing: 101] [Article Influence: 10.9] [Reference Citation Analysis]
85 Knoepfler PS. Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells. Regen Med 2012;7:713-20. [PMID: 22830621 DOI: 10.2217/rme.12.51] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
86 Wilson MA, Nathanson KL. Molecular testing in melanoma. Cancer J 2012;18:117-23. [PMID: 22453011 DOI: 10.1097/PPO.0b013e31824f11bf] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
87 Madorsky-Rowdo FP, Lacreu ML, Mordoh J. Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities. Front Immunol 2012;3:103. [PMID: 22566975 DOI: 10.3389/fimmu.2012.00103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
88 Ardini E, Galvani A. ALK Inhibitors, a Pharmaceutical Perspective. Front Oncol 2012;2:17. [PMID: 22655263 DOI: 10.3389/fonc.2012.00017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]